2020
DOI: 10.1111/jpc.14780
|View full text |Cite
|
Sign up to set email alerts
|

Central‐line‐associated bloodstream infections in a surgical paediatric intensive care unit: Risk factors and prevention with chlorhexidine bathing

Abstract: Aim The aims of the study are to evaluate the impact of a 4% chlorhexidine (CHG4%) bathing on the occurrence of central‐line‐associated bloodstream infection (CLABSI) and to identify risk factors (RFs) for CLABSI in our population. This is a retrospective monocentric cohort study in the paediatric surgical intensive care unit at the Necker Enfants Malades Hospital, Paris, France. Methods All hospitalised patients with central venous catheters (CVCs) in 2015 were included. CHG4% bathing was prescribed in CLABSI… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…1,3,5,8 However, it is believed that 65 to 70% of CRBSIs might be prevented. 9 One of the most important steps in the prevention of CRBSIs is nursing practices. 3 The care of CVCs falls within the direct and ongoing purview of nurses.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,3,5,8 However, it is believed that 65 to 70% of CRBSIs might be prevented. 9 One of the most important steps in the prevention of CRBSIs is nursing practices. 3 The care of CVCs falls within the direct and ongoing purview of nurses.…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies have shown how efficient it is at preventing CRBSIs in different ways. 9 15 16 The usefulness of chlorhexidine-impregnated (C-I) dressings as a barrier for bacterial penetration to the CVC insertion site and the efficacy of chlorhexidine in decreasing bioburden within the dressing during usage have been proven by the U.S. Food and Drug Administration. 15 In accordance with recent recommendations, patients who are 18 years of age or older should use C-I dressings to protect the location where CVCs are inserted.…”
Section: Introductionmentioning
confidence: 99%